JOURDAN WHORLEY: Open Payments
NPI 1083228621 · GATESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 10 payments from 7 companies in 2025. Trend: 2023 $77 · 2024 $51 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| Novo Nordisk Inc | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $14 |
Products named: QULIPTA, Wegovy, TRELEGY ELLIPTA, FARXIGA, ZEPBOUND, KEVEYIS, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
